Technology

Art

Alp Bio's AI platform predicts immune reactions to biologic drugs in early development

David Kertai

1d ago· 4 min readen

technology business ai in healthcare biotech

Summary

An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human immune tissue to help pharmaceutical companies predict immune reactions to biologic drugs early in development. The article covers how the platform works, the problem of immunogenicity in biologic drugs, and the company's approach to reducing late-stage drug failures.

Source

Twitter / XAlp Bio's AI platform predicts immune reactions to biologic drugs in early developmentvist.ly

Key quotes

· 3 pulled

Biologic drugs, such as therapeutic antibodies and other protein-based medicines, have transformed the treatment of many diseases, but they come with a significant challenge: the human immune system can recognize them as foreign and mount an immune response against them.

Our platform combines machine learning with laboratory-grown human immune tissue to identify potential safety risks early in drug development.

By predicting immune reactions earlier, we can help pharmaceutical companies make better decisions about which drug candidates to advance, saving time and resources.

Snippet from the RSS feed

The Center for Data Innovation recently spoke with Christian Vahlensieck, co-founder of Alp Bio, a Switzerland-based startup developing an AI-powered platform that helps pharmaceutical companies predict immune reactions to biopharmaceutical…

You might also wanna read

How AI Will Transform Biopharma: The Sequence of Change Matters

Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco

a16z.news·3d ago

Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification

Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove

blog.google·8mo ago

BIOS AI Platform for Biomedical Research Ranks #1 on BixBench Benchmark

BIOS is an AI-powered scientific research platform that ranked #1 on BixBench for biological data analysis. The system offers flexible resea

Product Hunt·4mo ago

AI Drug Discovery Stalled by Lack of Trustworthy Biological Data

The article discusses the gap between AI's potential in drug discovery and actual results, attributing the productivity gap to the quality a

the-scientist.com·1d ago

Tamarind Bio: AI Inference Platform for Drug Discovery Models

Tamarind Bio is an AI inference provider for drug discovery that offers a platform for biopharma companies to run leading open-source AI mod